entity

TRANSCRIPT

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TRANSCRIPT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections

30Hypotheses

0Analyses

3Outgoing

1Incoming

8Experiments

0Debates

No AI portrait yet

Outgoing (3)

Target	Relation	Type	Str
benchmark_ot_ad_answer_key:TRANSCRIPT	data_in	dataset_row	0.00
Distant Pqtl Effects	mediates	mechanism	0.88
protein_quantitative_trait_loci	mediates	phenotype	0.80

Incoming (1)

Source	Relation	Type	Str
benchmark_ot_ad_answer_key:TRANSCRIPT	data_in	dataset_row	0.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TBK1 Loss Locks Microglia in an Aged/Senescent Transcription	0.878	als	What are the mechanisms by which microgl
Transcriptional Autophagy-Lysosome Coupling	0.777	neurodegeneration	Autophagy-lysosome pathway convergence a
TREM2 Crosstalk and Synergistic Activation of Phagocytic Tra	0.761	neuroinflammation	What molecular mechanisms mediate SPP1-i
Metabolic Inflexibility Precedes Transcriptional Reprogrammi	0.735	neurodegeneration	What is the optimal therapeutic window f
H5: BET Bromodomain Readers Sense Aberrant Chromatin and Dri	0.690	neurodegeneration	Investigate mechanisms of epigenetic rep

TFEB-mediated transcriptional upregulation of lysosomal gene	0.679	neuroscience	Lysosomal dysfunction and cathepsin leak
H1: TET-Mediated 5-Hydroxymethylcytosine Loss Drives Neurona	0.670	neurodegeneration	Investigate mechanisms of epigenetic rep
m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein	0.662	parkinson	m6A RNA Modification and Alpha-Synuclein
m6A-dependent control of alpha-synuclein transcript fate and	0.626	neurodegeneration	m6A RNA Modification and Alpha-Synuclein
APOE ε4-driven microglial lipid handling as proximal driver	0.626	neurodegeneration	Non-Neuronal Transcriptional Changes Pre
ATF4-DDIT3 stress signaling indirectly represses MAPT transc	0.624	neurodegeneration	Which specific transcription factors med
Cell-state stratification is required to resolve Non-Neurona	0.612	neurodegeneration	Non-Neuronal Transcriptional Changes Pre
H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcr	0.610	neurodegeneration	Investigate mechanisms of epigenetic rep
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Non-Neuronal Transcriptional Changes Pre
HSF1 reprioritizes transcription and suppresses MAPT while r	0.598	neurodegeneration	Which specific transcription factors med
Spatial Transcriptome-Guided Precision Cell Therapy	0.578	neurodegeneration	Cell type vulnerability in Alzheimer's D
Direct NF-κB Transcriptional Regulation of C1q Genes in Micr	0.570	neuroinflammation	How does sevoflurane-induced NF-κB activ
TDP-43 Co-pathology Subtype Identified Through Motor Neuron	0.564	neurodegeneration	Methodology challenge: dataset 'Allen Br
Astrocytic SPP1 Modulation Through STAT3-Dependent Transcrip	0.551	neuroinflammation	What molecular mechanisms mediate SPP1-i
CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macr	0.535	neurodegeneration	How do perivascular cells specifically r
Epigenetic CRISPR/dCas9 Activation of PV Gene Program Preven	0.525	alzheimers	Closed-loop optogenetic targeting PV int
miR-143/145 Cluster Dysregulation Derepresses P2RY12 Transcr	0.520	neurodegeneration	What determines P2RY12 receptor expressi
AAV-PHP.eB-Medium OSK Expression Reverses Cortical Neuronal	0.520	neurodegeneration	epigenetic reprogramming aging neurons
Hippocampal-Cortical Transcriptomic Divergence Reveals Accel	0.519	alzheimer	Allen Mouse Brain Aging Atlas: cross-age
Hippocampus ages transcriptionally faster than cerebellum, d	0.516	alzheimers	Allen Mouse Brain Aging Atlas: cross-age
Transcriptome-wide competition determines functional selecti	0.509	molecular-neurobiology	How does lncRNA-0021 achieve sequence-sp
PKM2 nuclear translocation bridges metabolism and inflammato	0.506	neuroinflammation	Do microglia actually switch between gly
Early Postnatal TGF-beta Signaling Establishes Lifelong Regi	0.500	neuroinflammation	How do regional, age, and sex-dependent
YAP/TAZ Mechanosensing Cooperates with NF-κB to Amplify SPP1	0.492	neurodegeneration	How do perivascular cells specifically r
Astrocytic SPP1 Modulation via STAT3-Dependent Transcription	0.459	neuroinflammation	What molecular mechanisms mediate SPP1-i

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (8)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Autophagy Enhancement Drug Screening for Neurodegeneration	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$6,550,000
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Macroautophagy Dysfunction in PD - Experiment Design	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Validate Mitochondria-Lysosome Contact Site Dysfunction in PD	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,730,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
MLCS Quantification in Parkinson's Disease	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,730,000
Presymptomatic GRN Carrier Intervention Timing — Biomarker-Guided Ther	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu	validation	Neurodegeneration	0.400	0.50	human	proposed	$2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798]	Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang	Cell Mol Gastroenterol Hepatol	2024	1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704]	Zhang T, Xu D, Trefts E, Lv M, Inuzuka H	Science	2023	1
Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466]	Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji	J Ethnopharmacol	2022	1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892]	Wang Y, An H, Liu T, Qin C, Sesaki H, Gu	Cell Rep	2019	1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310]	Song X, Zhu S, Chen P, Hou W, Wen Q, Liu	Curr Biol	2018	1
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664]	Cid-Díaz T, Santos-Zas I, González-Sánch	J Cachexia Sarcopenia Muscle	2017	1
PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736]	Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K	Cell reports	2026	0
Mammalian lipophagy: process and function. [PMID:41681129]	Zhao R, Dai E, Kang R, Liu J, Klionsky D	Autophagy	2026	0
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828]	["Xin Y", "Sun Y", "Pan E", "Li M", "Che	Free radical biology & medicin	2026	0
Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545]	Cao X, Shang Y, Qu M, Kang Q, Xu Y et al	Phytomedicine	2026	0
Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754]	Contreras EJ, Nagarajan A, Bromberg BH,	Food Res Int	2026	0
FOXO1 transcription factor modulates airway epithelial responses to viral infect [PMID:41931532]	Daniel NM, Mann-Nüttel R, Shrestha Palik	PLoS One	2026	0
Effects of Vitamin A Restriction on Carcass Characteristics, Antioxidant Capacit [PMID:41856090]	Zhang X, Zhang C, Song J, Bai J, Hao B,	Animal bioscience	2026	0
Transcriptomic identification of CREB1 and FOXO1 activation in neuregulin-1-medi [PMID:41907189]	Bennett KR, Surles-Zeigler MC, Augello C	Frontiers in molecular neurosc	2026	0
Human MKP-3 isoforms display differential structural and functional profiles. [PMID:41865406]	Mori Sequeiros Garcia MM, Nudler S, Bigi	Biochemical and biophysical re	2026	0
Role of Uncertainty in Illness and Coping Strategies in Advance Directive Comple [PMID:38567890]	["Fuson O", "Mitra A", "Little C", "Hiat	Journal of clinical gastroente	2025	0
The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopath [PMID:39875022]	["Elbadawy N", "Saad M", "Elfarrash S",	European journal of pharmacolo	2025	0
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkins [PMID:39964974]	Dai L, Wang J, Meng L, Zhang X, Xiao T,	PLoS biology	2025	0
The multifaceted impact of physical exercise on FoxO signaling pathways. [PMID:40861274]	Liu W, Meng P, Li Z, Shen Y, Meng X, Jin	Frontiers in cell and developm	2025	0
Programmable protein stabilization with language model-derived peptide guides. [PMID:40229275]	["Hong L", "Ye T", "Wang T", "Srijay D",	Nature communications	2025	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning TRANSCRIPT in their description or question text

TFEB-mediated transcriptional upregulation of lysosomal genes as a therapeutic s

Score: 0.679 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** The transcription factor EB (TFEB) represents a master regulatory node in cellula

H1: TET-Mediated 5-Hydroxymethylcytosine Loss Drives Neuronal Transcriptomic Dri

Score: 0.670 · neurodegeneration · 2026-04-22

## Mechanistic Overview H1: TET-Mediated 5-Hydroxymethylcytosine Loss Drives Neuronal Transcriptomic Drift starts from t

m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein Transcript and Prom

Score: 0.662 · parkinson · 2026-04-27

N6-methyladenosine (m6A) hypermethylation of SNCA mRNA in substantia nigra dopaminergic neurons stabilises the transcrip

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetic

Score: 0.626 · neurodegeneration · 2026-04-28

m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetics should produce a measurable proximal p

APOE ε4-driven microglial lipid handling as proximal driver in Non-Neuronal Tran

Score: 0.626 · neurodegeneration · 2026-04-28

APOE ε4-driven microglial lipid handling should produce a measurable proximal phenotype before late disease pathology. T

ATF4-DDIT3 stress signaling indirectly represses MAPT transcription during prote

Score: 0.624 · neurodegeneration · 2026-04-25

Integrated stress response factors redirect transcription and chromatin regulation away from tau expression during acute

Cell-state stratification is required to resolve Non-Neuronal Transcriptional Ch

Score: 0.612 · neurodegeneration · 2026-04-28

The question is likely underpowered or misleading unless analyses preserve the key strata: RNA-, APOE. Averaging across

H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcription of Repetitive

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview H2: H3K9me3 Heterochromatin Collapse Enables Cryptic Transcription of Repetitive Elements starts

Perturbation-first validation should precede therapeutic claims for Non-Neuronal

Score: 0.608 · neurodegeneration · 2026-04-28

The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro

HSF1 reprioritizes transcription and suppresses MAPT while restoring proteostasi

Score: 0.598 · neurodegeneration · 2026-04-25

Heat-shock signaling either directly or indirectly reduces tau expression as chaperone programs dominate the stress resp

Spatial Transcriptome-Guided Precision Cell Therapy

Score: 0.578 · neurodegeneration · 2026-04-04

## Mechanistic Overview Spatial Transcriptome-Guided Precision Cell Therapy starts from the claim that modulating SOX10

Direct NF-κB Transcriptional Regulation of C1q Genes in Microglia

Score: 0.570 · neuroinflammation · 2026-04-21

## Mechanistic Overview Direct NF-κB Transcriptional Regulation of C1q Genes in Microglia starts from the claim that mod

TDP-43 Co-pathology Subtype Identified Through Motor Neuron Transcriptomics

Score: 0.564 · neurodegeneration · 2026-04-28

C9orf72-like transcriptional signature in layer 5 pyramidal neurons marks AD-TDP co-pathology. A subset of deep layer ex

Astrocytic SPP1 Modulation Through STAT3-Dependent Transcriptional Control

Score: 0.551 · neuroinflammation · 2026-04-20

## Mechanistic Overview Astrocytic SPP1 Modulation Through STAT3-Dependent Transcriptional Control starts from the claim

CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering

Score: 0.535 · neurodegeneration · 2026-04-22

## Mechanistic Overview CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macrophages, Triggering NF-κB-Dependent